Clinical trials were halted as COVID-19 took hold. But inability to see patients face-to-face has inspired the use of technology to monitor patients remotely, leading to improvements that are here to stay

A report by the European Parliament’s cancer special committee says the EU needs better coordination of cross-border clinical trials

Using anonymised information from electronic health records is an efficient and low-cost way of following up subjects years after the treatment phase of a study completes

Health programme is trying to reach its potential in the face of funding challenges that may be exacerbated by Brexit

Health insurers and pharma companies are striking pay-for-results deals under which rebates are offered if a drug does not perform as well in the real world as in clinical trials

Clinical trials are fundamental to the development of new treatments for cancer, but annual accrual to studies worldwide is low, at an estimated at three to five percent.